title: Role of Proteomics in the Development of Personalized Medicine.
abstract: Advances in proteomic technologies have made import contribution to the development of personalized medicine by facilitating detection of protein biomarkers, proteomics-based molecular diagnostics, as well as protein biochips and pharmacoproteomics. Application of nanobiotechnology in proteomics, nanoproteomics, has further enhanced applications in personalized medicine. Proteomics-based molecular diagnostics will have an important role in the diagnosis of certain conditions and understanding the pathomechanism of disease. Proteomics will be a good bridge between diagnostics and therapeutics; the integration of these will be important for advancing personalized medicine. Use of proteomic biomarkers and combination of pharmacoproteomics with pharmacogenomics will enable stratification of clinical trials and improve monitoring of patients for development of personalized therapies. Proteomics is an important component of several interacting technologies used for development of personalized medicine, which is depicted graphically. Finally, cancer is a good example of applications of proteomic technologies for personalized management of cancer.
authors.affiliation: Jain PharmaBiotech, Basel, Switzerland. Electronic address: jain@pharmabiotech.ch.
authors.forename: Kewal K
authors.initials: KK
authors.lastname: Jain
mesh_terms: D006801:Humans; D036103:Nanotechnology / Q000639:trends; D010597:Pharmacogenetics / Q000639:trends*; D057285:Precision Medicine / Q000639:trends*; D040081:Protein Array Analysis / Q000639:trends*; D040901:Proteomics / Q000639:trends*
keywords: Biomarkers; Molecular diagnostics; Nanoproteomics; Personalized medicine; Pharmacoproteomics; Protein biochips; Proteodiagnostics; Proteomic technologies; Proteomics